Helius Medical Technologies, Inc. (NASDAQ:HSDT) Short Interest Update

Helius Medical Technologies, Inc. (NASDAQ:HSDT) was the target of a large growth in short interest in March. As of March 15th, there was short interest totalling 66,300 shares, a growth of 247.1% from the February 28th total of 19,100 shares. Based on an average daily trading volume, of 4,400,000 shares, the short-interest ratio is currently 0.0 days. Currently, 1.9% of the shares of the stock are short sold.

Institutional Investors Weigh In On Helius Medical Technologies

A hedge fund recently bought a new stake in Helius Medical Technologies stock. Virtu Financial LLC purchased a new position in Helius Medical Technologies, Inc. (NASDAQ:HSDT) during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 46,510 shares of the company’s stock, valued at approximately $31,000. Virtu Financial LLC owned 1.25% of Helius Medical Technologies at the end of the most recent quarter. 18.63% of the stock is owned by hedge funds and other institutional investors.

Helius Medical Technologies Trading Up 4.5 %

Shares of NASDAQ:HSDT traded up $0.02 during trading on Friday, reaching $0.42. The company’s stock had a trading volume of 54,880 shares, compared to its average volume of 1,399,932. The stock has a market capitalization of $1.57 million, a PE ratio of -0.07 and a beta of 1.62. Helius Medical Technologies has a 12 month low of $0.37 and a 12 month high of $7.19. The firm’s 50 day simple moving average is $0.54 and its two-hundred day simple moving average is $0.59.

Helius Medical Technologies (NASDAQ:HSDT) last released its quarterly earnings results on Tuesday, March 25th. The company reported ($1.03) EPS for the quarter, missing analysts’ consensus estimates of ($0.94) by ($0.09). Helius Medical Technologies had a negative return on equity of 244.82% and a negative net margin of 1,764.74%. The firm had revenue of $0.15 million for the quarter, compared to analysts’ expectations of $0.10 million.

Helius Medical Technologies Company Profile

Helius Medical Technologies, Inc, a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator, a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise.